Is It Worth Appealing a CHC Funding Decision? An Honest Answer

Every CHC advocacy site says the same thing about a refused decision: appeal. The advice is reflexive, well-meaning, and incomplete. Some refusals are correct refusals — and 12 to 18 months of fighting a decision the evidence does not support is a real cost in stress, time, and money.

This guide is the honest version. It puts the published success-rate data next to the published care-cost data, walks through the cost/benefit maths most advocacy sites won't show you, and ends with a £97 evidence triage that exists specifically because the rational first move is not appealing — it is finding out whether the evidence supports an appeal.

Reviewed by legal professionals and social care professionals.

TL;DR: A CHC appeal is worth pursuing when the evidence supports a primary health need — not by default. Local Resolution reverses about 13% of refusals (Nuffield Trust, 2024); a refused nursing-care year averages £75,244 (Laing Buisson, 2024-25). The expected value is positive — but only with strong evidence. Start with a £97 evidence triage.

---

What does the data actually say about CHC appeal success?

The most rigorous published figure is from Nuffield Trust's June 2024 analysis of NHS England data: of 596 Local Resolution requests in Q4 2023/24, 13% resulted in eligibility being granted (Nuffield Trust, June 2024). That is the honest national average — roughly one in eight ICB decisions reversed at first appeal on the same evidence, before any new records are submitted.

Two caveats matter. First, the 13% is the national average across cases of all evidence strengths. Cases run with a structured DST-domain evidence pack — incident logs, GP records, family statement, and case-law-grounded reasoning on primary health need — typically perform meaningfully better than the average. Second, NHS England does not publish a national overturn rate for the Independent Review Panel stage. Commercial providers cite a range of figures, but the primary-source transparency is missing — a gap the system itself should fix, and one to ask about when comparing CHC service providers.

The upstream context tells the same story. Eligibility at full CHC assessment has fallen from 31% in Q1 2017/18 to 17% in Q1 2025/26 (Healthwatch England, October 2025). Most refusals today are systemic, not personal — which is precisely why an evidence-led appeal often succeeds where the original assessment did not. For the wider numbers on who actually qualifies, see our guide to who qualifies for CHC funding in 2026.

---

How much is a successful CHC appeal actually worth?

A successful appeal removes the entire bill for the disputed period of care and frequently includes backdated refunds for fees already paid. Laing Buisson's 2024-25 Care of Older People UK Market Report puts the average self-funder care home bill at £57,200 per year for residential care and £75,244 per year for nursing care in England (Laing Buisson, 2024-25). Each year of CHC eligibility, if upheld, removes that whole liability.

The cost asymmetry is sharper than headline averages suggest. Self-funders pay on average £370 per week more than local authorities for the same care home places — roughly £19,000 a year in price discrimination (Laing Buisson, 2024-25). Care homes use self-funder rates to cross-subsidise loss-making council-funded residents. A successful CHC appeal does not just stop the bill; it stops the cross-subsidy.

Retrospective claims add a separate dimension. The Previously Unassessed Period of Care (PUPoC) process can recover fees paid back as far as April 2012 in some circumstances, and multi-year retrospective claims regularly run into six figures. PUPoC is a different procedure from the standard appeal — see our retrospective CHC claims guide for the rules and timing.

The headline number for a typical case: a single year of successfully reversed self-funded nursing care saves around £75,000. Add backdated months at the same rate, and a two-year dispute that resolves in the family's favour can clear £150,000–£200,000 of care fees.

---

What does a CHC appeal actually cost — in time, energy, and money?

A two-stage appeal — Local Resolution followed by the Independent Review Panel — typically takes 9 to 18 months end to end. The 2022 National Framework targets three months at each stage, but published industry commentary puts realistic wait times at 3–6 months for Local Resolution and a further 8–12 months for the IRP (Care To Be Different, industry commentary, 2024). Healthwatch's October 2025 review described the experience plainly: appealing was "possible, but often painful and confusing, with people describing a lack of communication and compassion among those involved" (Healthwatch England, October 2025).

The time cost is the underestimated one. In CareAdvocate's casework with families preparing structured appeal packs — Subject Access Request to multiple bodies, domain-by-domain evidence mapping, family statement, citation of the primary health need legal test and the well-managed needs rebuttal — a thorough family-run pack typically takes 30 to 60 hours of focused work, often more. For a family already delivering day-to-day care, that bandwidth is rarely available without sacrifice elsewhere.

If you hire specialist support, current published market rates run from £1,600 plus VAT (£1,920) for Beacon CHC's post-rejection Expert Analysis (beaconchc.co.uk), through full advocacy retainers in the low five figures, to no-win-no-fee solicitor models that take 25–40% of any refund recovered. Each model has rational use cases; none is the right starting point for every family.

The honest accounting: an appeal is "free" in NHS terms but expensive in family terms — and the family-time cost is the one most likely to derail a case that should have succeeded on the evidence. For the time-limit mechanics that decide when this work has to start, see our CHC appeal time-limit guide.

---

When does the cost/benefit maths favour appealing?

For most families paying full self-funder rates, the maths favours appealing whenever the evidence is at least moderately supportive of a primary health need. A 13% baseline probability of reversing a refusal — rising for evidence-led cases — applied to £57,200–£75,244 of avoided annual care fees gives an expected value comfortably above the time and money cost of running the appeal. The maths does the work; the only variable that matters is evidence strength.

A workable decision framework, in four questions:

• How strong is the medical evidence? Multiple disputed DST domains with dated entries from care records, GP files, specialist letters, and incident logs is "strong". Memory and the original DST score alone is "limited" — that is the gap a Case Strength Report exists to size.
• How much self-funded care is in scope? Both forward (every year the relative remains eligible) and backward (retrospective period under PUPoC if applicable). The longer the period, the higher the expected value of a successful appeal.
• Is the family's bandwidth real? A 30–60-hour appeal pack spread over six to eight weeks is doable for some families and not for others. The honest answer determines whether the work is DIY or supported.
• Does the refusal letter rely on "well-managed" reasoning? If so, the rebuttal pattern based on paragraphs 119–121 of the 2022 National Framework materially raises the success probability above the 13% national average.

Two or more "yes" answers in this framework is a strong signal to pursue. Two or more "weak" answers is a signal to triage the evidence cheaply before committing — not to walk away, but to find out.

---

When is appealing probably not worth it?

Some CHC refusals are correct refusals. Where the relative's needs are predominantly social — personal care, prompting, supervision — and clinically stable without skilled interventions, the appeal route is unlikely to succeed and the time cost is real. The 2022 National Framework requires a primary health need demonstrated through the nature, intensity, complexity, or unpredictability of need; an appeal that cannot engage any of those four characteristics on the evidence usually fails.

Three patterns where appealing is most likely the wrong move:

• Predominantly social-care needs — personal care, companionship, prompting — without high clinical complexity, unpredictable behaviours, or skilled clinical intervention requirements. The Care Act 2014 social-care framework, not CHC, is the right route here.
• Needs that have measurably reduced since the original assessment — recovery from a hospital admission, stabilisation on a new medication regime, removal of a previously high-risk behaviour. A fresh referral may be more appropriate than an appeal of the older decision.
• Procedurally clean assessments where the right evidence was already considered, the MDT was properly constituted, and the decision letter engages the Coughlan limbs with reasons. Process grounds are usually the strongest grounds; without them, appeal success rates fall sharply.

The contrarian point is not that families should walk away from refusals lightly — most refusals contain evidence-level errors worth challenging. The point is that "always appeal" is a marketing-driven answer, not an evidence-driven one. A good advocate will sometimes tell a family the evidence is not there. That honest no is part of what makes the next honest yes worth trusting.

---

The £97 first step — why evidence triage beats blind appealing

Before committing to a 12–18-month appeal, find out for £97 whether the evidence actually supports one. The Case Strength Report reviews the relative's available records, the Checklist or DST outcome, and the refusal letter — and returns a structured view of evidence strength against the primary health need test. Strong, Partial, or Limited. With reasons. Within five working days.

The analogy that fits: this is the homebuyer's survey of CHC appeals. Nobody commits to a £300,000 property without a survey; the survey is rational risk pricing, not a sales funnel. Yet families routinely commit to 18-month appeals — and sometimes to no-win-no-fee contracts that take 25–40% of any refund — without an evidence triage step. The £97 fee is set at a price that is small relative to the decision it informs, and meaningfully below the £1,920 Beacon CHC charges for an equivalent post-rejection Expert Analysis (beaconchc.co.uk).

What the Case Strength Report does and does not do: it is not the £597 Checklist Evidence Pack — that is the full assessor-facing document for families who have decided to proceed. It is not legal advice. It is not an outcome guarantee. It is a structured, sourced, human-reviewed view of whether the medical record on file engages the Coughlan test — and a clear recommendation on what to do next.

Some Case Strength Reports come back recommending against appeal. We tell families when the evidence does not support a primary health need. That is not good for short-term revenue, but it is the entire reason the £597 Checklist Evidence Pack and the appeal-stage products are worth what we charge for them when we do recommend proceeding.

---

What this means for your decision

The honest answer to "is it worth appealing a CHC funding decision?" is it depends on the evidence — not the reflexive always appeal answer most advocacy sites give. The published data supports this position: 17% national eligibility, 13% Local Resolution overturn average, no published IRP rate, £57,200–£75,244 per disputed care year at stake. For an evidence-strong case those numbers add up to a positive expected value. For an evidence-thin case they do not.

The decision is rarely binary on day one. Three rational paths exist:

• Evidence-strong case → file Local Resolution within the 6-month time limit, build the structured pack, follow our complete appeal guide.
• Evidence-uncertain case → start with the £97 Case Strength Report. Five working days, structured rating, honest recommendation either way.
• Evidence-weak case → consider a fresh referral if needs have changed, or accept the refusal and pursue a means-tested social-care route under the Care Act 2014.

Not refused yet, or unsure if a referral is worth requesting in the first place? The free CHC eligibility screener takes four minutes and runs against the National Framework criteria. For families weighing the contrarian honest answer against the standard always appeal advice, that four-minute screener plus a £97 Case Strength Report is the rational risk pricing the advocacy industry rarely offers — and the place this guide is designed to lead.

This guide is reviewed by legal professionals and social care professionals. CareAdvocate provides advocacy and evidence preparation, not legal advice. Success-rate statistics are sector-wide NHS England figures; CareAdvocate does not guarantee outcomes, and individual cases vary. The Case Strength Report uses Strong / Partial / Limited evidence ratings; A/B/C domain levels are reserved for the Checklist Evidence Pack assessor-facing document.